AGEIX
Price
$7.77
Change
-$0.02 (-0.26%)
Updated
Sep 11 closing price
Net Assets
1.96B
MEDAX
Price
$12.50
Change
-$0.08 (-0.64%)
Updated
Sep 11 closing price
Net Assets
7.5B
Interact to see
Advertisement

AGEIX vs MEDAX

AGEIX vs MEDAX Comparison Chart in %
View a ticker or compare two or three
VS
AGEIX vs. MEDAX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEIX is a Hold and MEDAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDAX has more cash in the bank: 7.5B vs. AGEIX (1.96B). AGEIX pays higher dividends than MEDAX: AGEIX (9.85) vs MEDAX (5.33). AGEIX was incepted earlier than MEDAX: AGEIX (13 years) vs MEDAX (29 years). MEDAX (1.08) and AGEIX (1.07) have similar cost to investors . MEDAX is a more actively managed with annual turnover of: 69.00 vs. AGEIX (34.00). MEDAX has a lower initial minimum investment than AGEIX: MEDAX (1000) vs AGEIX (250000). AGEIX annual gain was more profitable for investors over the last year : 17.06 vs. MEDAX (5.04). AGEIX return over 5 years is better than : 49.30 vs. MEDAX (10.88).
AGEIXMEDAXAGEIX / MEDAX
Total Expense Ratio1.071.07100%
Annual Report Gross Expense Ratio1.071.0899%
Fund Existence13 years29 years-
Gain YTD9.7291.601608%
Front LoadN/A4%-
Min. Initial Investment250000100025,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.96B7.5B26%
Annual Yield % from dividends9.855.33185%
Returns for 1 year17.065.04339%
Returns for 3 years59.6630.90193%
Returns for 5 years49.3010.88453%
Returns for 10 years112.9437.49301%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGRX84.231.04
+1.25%
Putnam Small Cap Growth R
HDGIX39.000.37
+0.96%
Hartford Dividend and Growth I
TSPRX5.080.04
+0.79%
Transamerica Small Cap Growth R
BRUDX19.640.15
+0.77%
MFS Blended Research Value Equity A
PGLEX22.920.14
+0.61%
Putnam Focused International Equity R6